Rod Dashwood is a University Distinguished Professor who joined Texas A&M Health as inaugural Director of the Regents Designated Center for Epigenetics & Disease Prevention and John S. Dunn Chair in Disease Prevention. Tenure resides within the Dept. Translational Medical Sciences, Texas A&M College of Medicine, with affiliate faculty roles in the Dept. Nutrition and MD Anderson Cancer Center. A Fellow of the Royal Society of Biology, he received Regents’ Medals for Excellence in Teaching and Research, and the Rice University Biosciences & Bioengineering Medical Innovation Award. His research dovetails epigenetic and immune approaches for precision oncology and cancer prevention, including dietary regulators of the antigen presentation pathway. In vivo and cell-based assays are integrated with clinical specimens and patient-derived organoids. Supported by the NCI Division of Cancer Prevention and the John S. Dunn Foundation.